Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial (Q40693199)
Jump to navigation
Jump to search
scientific article published on 26 April 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial |
scientific article published on 26 April 2016 |
Statements
1 reference
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial (English)
1 reference
Jonathan Corren
1 reference
Sally Wenzel
1 reference
Mario Castro
1 reference
Jorge Maspero
1 reference
Lin Wang
1 reference
Bingzhi Zhang
1 reference
Gianluca Pirozzi
1 reference
E Rand Sutherland
1 reference
Robert R Evans
1 reference
Vijay N Joish
1 reference
Laurent Eckert
1 reference
Neil M H Graham
1 reference
Neil Stahl
1 reference
George D Yancopoulos
1 reference
Mariana Louis-Tisserand
1 reference
Ariel Teper
1 reference
26 April 2016
1 reference
1 reference
388
1 reference
10039
1 reference
31-44
1 reference
Identifiers
1 reference
1 reference